Stage 1 mixed cellularity Hodgkin lymphoma is often highly treatable, and many patients achieve long-term remission after frontline therapy. Advances in chemotherapy, radiation techniques and targeted ...
For Hai Trinh, his disease started gradually. Fatigue. Bruising easily. He thought little of it.As a mechanic, husband and ...
A South Shields man who was told his shoulder pain was caused by acid reflux later discovered he has incurable blood cancer.
He died two days after undergoing a biopsy, as his condition worsened until his death. For these events, with the charge of ...
A pediatrician examining Annie Smith’s older brother noticed a bruise on the 6-year-old’s leg — which led to a rare and ...
Manage your stage 3 ET diagnosis with this guide on high-risk treatments, side effects and new NCCN-preferred options to empower your next visit. While essential thrombocythemia (ET) is classified as ...
An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing ...
Executives from Geron (NASDAQ:GERN) outlined their commercial priorities for RYTELO (imetelstat) and provided updates on the company’s pipeline and financial outlook during a discussion hosted by ...
A grandad-of-two was diagnosed with a life-threatening blood cancer after feeling "unusually tired." Harish Nersian, 73, went ...
A BTK inhibitor combined with standard R-CHOP produced rapid, PET-defined complete remission in high-risk DLBCL-type Richter syndrome with TP53 deletion. Delaying ibrutinib until cycle 2 was used as a ...
During a live event, Marc J. Braunstein, MD, PhD, and participants discussed maintenance lenalidomide and daratumumab as well as the clinical potential of MRD in multiple myeloma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results